Latitude Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
1,513
+231
+18% +$236K 0.72% 30
2026
Q1
$1.18M Sell
1,282
-256
-17% -$260K 0.54% 47
2025
Q4
$1.65M Sell
1,538
-75
-5% -$71.7K 0.73% 29
2025
Q3
$1.23M Sell
1,613
-282
-15% -$210K 0.56% 39
2025
Q2
$1.48M Sell
1,895
-351
-16% -$273K 0.74% 28
2025
Q1
$1.86M Buy
2,246
+993
+79% +$826K 1.08% 18
2024
Q4
$967K Sell
1,253
-44
-3% -$36.4K 0.54% 47
2024
Q3
$1.15M Buy
1,297
+33
+3% +$29.7K 0.65% 35
2024
Q2
$1.14M Sell
1,264
-26
-2% -$20.8K 0.7% 29
2024
Q1
$1M Buy
1,290
+16
+1% +$11.4K 0.63% 30
2023
Q4
$743K Buy
1,274
+60
+5% +$35K 0.52% 41
2023
Q3
$652K Buy
1,214
+30
+3% +$15.5K 0.47% 46
2023
Q2
$555K Buy
1,184
+348
+42% +$146K 0.39% 57
2023
Q1
$287K Sell
836
-193
-19% -$65.1K 0.21% 119
2022
Q4
$376K Sell
1,029
-503
-33% -$178K 0.28% 91
2022
Q3
$495K Buy
1,532
+18
+1% +$5.7K 0.41% 51
2022
Q2
$490K Sell
1,514
-3,199
-68% -$960K 0.45% 57
2022
Q1
$1.35M Buy
4,713
+117
+3% +$30.1K 0.3% 75
2021
Q4
$1.27M Buy
4,596
+344
+8% +$87.2K 0.35% 49
2021
Q3
$982K Buy
4,252
+2,184
+106% +$539K 0.31% 60
2021
Q2
$475K Buy
2,068
+65
+3% +$13.1K 0.35% 63
2021
Q1
$374K Buy
2,003
+802
+67% +$157K 0.31% 78
2020
Q4
$203K Buy
+1,201
New +$179K 0.18% 129

Other funds holding LLY

Latitude Advisors's LLY Position: Q2 2026 in Review

Latitude Advisors increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $236K and bringing the position to 1,513 shares worth $1.82M. The position accounts for 0.72% of the portfolio, ranked #30.

Latitude Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.86M in Q1 2025. 2,134 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Latitude Advisors held 1,513 shares of Eli Lilly worth $1.82M as of Q2 2026.
  • Latitude Advisors bought 231 Eli Lilly shares in Q2 2026, an estimated $236K.
  • Eli Lilly made up 0.72% of Latitude Advisors's portfolio in Q2 2026, its #30 holding.
  • Latitude Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Latitude Advisors's Eli Lilly position peaked at $1.86M in Q1 2025.
  • 2,134 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Latitude Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.